A detailed history of Tci Wealth Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Tci Wealth Advisors, Inc. holds 16,379 shares of ABBV stock, worth $2.81 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
16,379
Previous 17,043 3.9%
Holding current value
$2.81 Million
Previous $2.64 Million 12.91%
% of portfolio
0.31%
Previous 0.29%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$159.82 - $182.1 $106,120 - $120,914
-664 Reduced 3.9%
16,379 $2.98 Million
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $22,704 - $25,570
165 Added 0.98%
17,043 $2.64 Million
Q3 2023

Oct 31, 2023

BUY
$133.59 - $154.65 $55,573 - $64,334
416 Added 2.53%
16,878 $2.52 Million
Q2 2023

Aug 04, 2023

BUY
$132.51 - $164.9 $2,385 - $2,968
18 Added 0.11%
16,462 $2.22 Million
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $43,961 - $50,628
-304 Reduced 1.82%
16,444 $2.62 Million
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $3,734 - $4,478
-27 Reduced 0.16%
16,748 $2.71 Million
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $19,057 - $21,858
142 Added 0.85%
16,775 $2.25 Million
Q2 2022

Jul 19, 2022

BUY
$137.62 - $174.96 $30,001 - $38,141
218 Added 1.33%
16,633 $2.55 Million
Q1 2022

Apr 29, 2022

BUY
$131.98 - $163.75 $68,233 - $84,658
517 Added 3.25%
16,415 $2.66 Million
Q4 2021

Jan 24, 2022

SELL
$107.43 - $135.93 $21,271 - $26,914
-198 Reduced 1.23%
15,898 $2.15 Million
Q3 2021

Oct 29, 2021

SELL
$106.4 - $120.78 $143,852 - $163,294
-1,352 Reduced 7.75%
16,096 $1.74 Million
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $116,677 - $129,985
1,109 Added 6.79%
17,448 $1.97 Million
Q1 2021

Apr 29, 2021

BUY
$102.3 - $112.62 $11,253 - $12,388
110 Added 0.68%
16,339 $1.77 Million
Q4 2020

Jan 21, 2021

SELL
$80.49 - $108.67 $238,330 - $321,771
-2,961 Reduced 15.43%
16,229 $1.74 Million
Q3 2020

Oct 20, 2020

BUY
$85.91 - $100.83 $57,387 - $67,354
668 Added 3.61%
19,190 $1.68 Million
Q2 2020

Jul 20, 2020

SELL
$73.37 - $98.18 $440 - $589
-6 Reduced 0.03%
18,522 $1.82 Million
Q1 2020

Apr 14, 2020

SELL
$64.5 - $97.79 $62,371 - $94,562
-967 Reduced 4.96%
18,528 $1.41 Million
Q4 2019

Jan 27, 2020

SELL
$72.13 - $90.25 $100,982 - $126,350
-1,400 Reduced 6.7%
19,495 $1.73 Million
Q3 2019

Oct 17, 2019

BUY
$62.98 - $75.72 $138,556 - $166,584
2,200 Added 11.77%
20,895 $1.58 Million
Q2 2019

Jul 23, 2019

SELL
$65.7 - $83.98 $4,993 - $6,382
-76 Reduced 0.4%
18,695 $1.36 Million
Q1 2019

Apr 11, 2019

SELL
$77.14 - $90.79 $3,702 - $4,357
-48 Reduced 0.26%
18,771 $1.51 Million
Q4 2018

Jan 17, 2019

SELL
$77.85 - $96.01 $56,207 - $69,319
-722 Reduced 3.69%
18,819 $1.74 Million
Q3 2018

Nov 02, 2018

BUY
$88.91 - $98.84 $6,934 - $7,709
78 Added 0.4%
19,541 $1.85 Million
Q2 2018

Jul 27, 2018

BUY
$89.78 - $106.23 $2,154 - $2,549
24 Added 0.12%
19,463 $1.8 Million
Q1 2018

Apr 30, 2018

SELL
$92.01 - $123.21 $24,290 - $32,527
-264 Reduced 1.34%
19,439 $1.84 Million
Q4 2017

Feb 01, 2018

BUY
$89.56 - $98.21 $53,736 - $58,925
600 Added 3.14%
19,703 $1.91 Million
Q3 2017

Oct 24, 2017

BUY
$69.85 - $89.22 $56,788 - $72,535
813 Added 4.45%
19,103 $1.7 Million
Q2 2017

Aug 10, 2017

BUY
N/A
18,290
18,290 $1.33 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.